Aim: Infections and sepsis are the leading causes of death in non-cardiac ICUs and account for 40 percent of all ICU expenditures. Data regarding bloodstream infections (BSIs) due to a carbapenem-resistant gram negative (CRGN) microorganis in pediatric ICUs still remain limited. Materials and Methods: This study was conducted retrospectively in patients who were admitted to two pediatric critical care units between January 2011 and December 2017. Patients were assigned to two groups. Patients with bloodstream infection (BSI) caused by a carbapenem-resistant gramnegative microorganism and infections were assigned to BSI group other than BSI were assigned to non-BSI group. Results: This study included 96 critically ill children with a mean age of 48.6 (1-204) months.Requirement of invasive procedures included tracheostomy, foley catheter and central venous catheter were not statistically different among groups, P values were 0.159, 0.291 and 0.803, respectively. The majority of the patients admitted to PICU due to sepsis/septic shock in BSI group (n: 18, 58%) and in non-BSI group (n: 24, 37,9%). Prior third/fourth generation cephalosporin exposure significantly more common in BSI group (51.6% vs.15.5%, P<0.001), carbapenem exposure was not significantly different among groups (35.5% vs 56.9%, P=0.054). Neutropenia (<500/mm 3 ) and thrombocytopenia (150x103/mm 3 ) were more significantly more common in BSI group (P=0.011 and P=0.010) and C-reactive protein (CRP) level was significantly higher (P=0.018). Crude and attributable mortality did not show significance between groups, P values were 0.578 and 0.955, respectively. Conclusion: Carbapenem -resistant gram-negative infections are still major cause of morbiditity, mortality and healthcare associated infections. In this sudy, we evaluated the patients with BSI due to a CRGN microorganism and compared with other infection types. The risk factors and outcomes were similar except prior cephalosporin exposure. As a conclusion, we have to enhance the infection control programs and prevent the patients from redundant antibiotic exposure.
Introduction
Antibiotic resistance across gram-negative bacteria has progressively disseminated to countries worldwide, presenting a serious public health concern. Although intensive care units (ICUs) account for fewer than 10 percent of total beds in most hospitals, majority of all healthcare associated infections occurred in ICU Departments of hospitals (1, 2) . Infections and sepsis are the leading causes of death in non-cardiac ICUs and account for 40 percent of all ICU expenditures (3) . A recent review evaluated carbapenemresistant Enterobacteriaceae (CRE) infections reported that the majority of children (53%) acquired carbapenem-resistant gram negative (CRGN) infections during ICU stay (4). Vincent JL et al. (3) concluded that infections have been common in patients in contemporary ICUs, and longer duration hospital stay correlated with risk of infection. Infections due to CRE in adult populations have been associated with poor clinical outcomes, including mortality rates as high as 40-65% while mortality can reach up to 90% in children (4, 5) . Data regarding bloodstream infections (BSIs) due to a CRGN pathogen in pediatric ICUs still remain limited (6, 7) . Therefore, we evaluated the clinical and laboratory features of BSIs caused by a CRGN pathogen and compared with other type of infections included urinary tract infection (UTI), ventilator-associated pneumonia (VAP) and meningitis.
Material and Methods
This study was conducted retrospectively in patients who were admitted to two pediatric critical care units between January 2011 and January 2017. Demographic characteristics, medical history, comorbidity, pathogens isolated and antimicrobial susceptibility of isolated pathogens, treatment administered, administration of other nephrotoxic agents, duration of PICU stay before isolation of resistant microorganisms, presence of medical devices, such as central catheters, urinary catheters, and endotracheal or tracheostomy tubes, ventriculo-peritoneal device were recorded retrospectively from medical records.
Microbiologic Testing
Presumptive identification of Gram-negative pathogens was identified by VITEK MS (bioMérieux, France). Vitek-MS that is using Matrix assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) technology which is a new technology for species identification based on the protein composition of microbial cells. The isolate was tested for antibiotic sensitivity on Muller Hinton agar by Kirby Bauer disc diffusion technique using standard methods. The susceptibilities of amikacin, ceftriaxone, ceftazidime, piperacillin-tazobactam, cefoperazone-sulbactam, imipenem, meropenem, colistin and tygecycline were determined according to Clinical and Laboratory Standards Institutes (CLSI) guidelines. Definitions
We reviewed the medical records of the enrolled patients and collected the case information. A standard form was used to collect the epidemiologic data including age, sex, underlying diseases (pulmonary disease, malignancy, cardiovascular disease, hematologic/solid organ transplantation, metabolic disease, genetic syndrome, prematurity, renal disease, liver disease), medication or intervention (presence of tracheal cannula, central venous catheter, presence of a Foley catheter, mechanical ventilation, immunosuppressive therapy and steroid, receipt of antibiotics). Diagnosis of infection was based on clinical features and isolation of bacteria from normally sterile site. A patient with CRGN BSI was defined as BSI group and the patients with other infection types such as VAP, UTI and meningitis were included in non-BSI group. Standard definitions of nosocomial infections and ventilator associated pneumonia (VAP) were used according to the Center for Disease Control and Prevention (CDC) definitions (13) and diagnosis of sepsis was made according to International Pediatric Sepsis Consensus (14) .
Crude mortality was defined if a patient died 1 month within infection and attributable mortality was defined if a patient died directly related to breakthrough infection.
Statistical Analysis
Statistical analyses were performed using SPSS for Windows ( 
Results
This study included 96 critically ill children with a mean age of 48.6 (1-204) months between January 2011 and December 2017. The most common type of infection was VAP (59 cases, 66,2%), followed by BSI (31 cases, 39.6%), UTI (10 cases, 11.2%), meningitis (3 cases, 3.3%). Both bloodstream infection and VAP occurred in 7 (7.8%) patients, BSI and UTI occurred 3 (3.3%) patients and VAP and UTI occurred in 3 (3.3%) patients. The most common underlying disease was chronic neurological disorder in BSI group (n:9, 29%) and non-BSI groups (n:18, 31%) and followed by bone marrow/ solid organ transplantation (n:7, 22.5%) while chronic lung diseases (n:9, 15.5%) in non-BSI group (Table I ). The majority of the patients admitted to PICU due to sepsis/septic shock in BSI group (n:18, 58%) and in non-BSI group (n:24, 37,9%). Requirement of invasive procedures included tracheostomy, foley catheter and central venous catheter were not statistically different among groups, P values were 0.159, 0.291 and 0.803, respectively. The mean age of the patients significantly younger in BSI group than non-BSI group (12 vs.32, P=0.022). Total and prior hospital stay did not show significant difference, P levels were 0.384 and 0.803, respectively. Prior third/fourth generation cephalosporin exposure significantly 
Discussion
In this study, a retrospective case-control study was conducted to evaluate the risk factors for acquisition of BSI caused by CRGN microorganism and to compare with other infection types other than BSI in patients those admitted to PICUs of two teaching hospitals. We found BSIs occurred in younger patients and thrombocytopenia and neutropenia were significantly more common in BSI group. The crude and attributable mortality rate did not show statistical significance between the groups. Over recent years, CRGN infections have been accused as a significant cause of healthcare associated infections, significant mortality and morbidity. Previous adult studies suggested that elder patients are more vulnerable to CRE infections. On the other hand, a recent study from UK evaluating CRE infections, demonstrated majority of the patients (6/9; 66.6%) were under 1 year of age (8) . Similarly, we found that patients with BSI younger than the patients with other types of infection. A recent study evaluated the risk factors and clinical outcomes of patients with CR Acinetobacter baumanni bacteremia and found that the independent risk factors were hematological malignancy, previous cefepim exposure and the use of total parenteral nutrition (9). Routsi et al. (10) suggested prior exposure to carbapenems were independent risk factors for acquisition of CR-GNB. Previous administration of carbapenems was the only factor related with the development of CR-GNB if the source of infection was other than VAP. Patients with bacteremia were more likely to have additional devices and longer hospital stay. In the present study, carbapenem exposure rate was similar among groups while prior cephalosporin 3-fold more common in BSI group when compared with non-BSI group (<0.001).
A recent mataanalysis evaluating 9 studies reported that death rates were higher in patients had bacteremia caused by a CRGN pathogen when compared with a CSGN pathogen. However, they suggested no difference between groups; bacteremia and other infections (11) . We compared the patients with BSI caused by a CRGN pathogen and other types of infection due to a CRGN pathogen and not found a significant difference. A case control study has been used to identify the risk factors and compare the outcomes (12) . Previous studies demonstrated 3-6 times higher mortality among CRE-infected patients when compared with Carbapenem-sensitive Enterobacterieaceae infected patients (13) (14) (15) . We did not find significant difference among groups.
Acquired risk factors for CRE infection in children include underlying chronic medical conditions, invasive medical devices, frequent or prolonged hospitalizations, prior antibiotic exposure, age, and travel from endemic regions (13) . Among BSI and non-BSI groups, prior and total hospital stay duration did not show difference.
Thrombocytopenia is a common finding in patients with bacterial sepsis as a result of marrow suppression, consumption due to DIC and inflammatory response, and/or drug-induced. A recent study compared methicillin-resistant and methicillin-sensitive S.aureus infected patients and found no significant difference for thrombocytopenia (16) . A recent multicenter observational study demonstrated that thrombocytopenia within the first 24 hours of septic shock onset as a prognostic marker of survival at day 28 in a large cohort of ICU patients (17) . We found that patients in BSI group significantly more likely to develop thrombocytopenia as previous reports.
There are several advantages of this study. The main advantage is to be the largest series in pediatric critical care settings and to be the first study that evaluates the impact of having a BSI due to a CRGN pathogen and multicenter design. The main limitations of this study were the retrospective design and lack of molecular characterization of microorganisms which can affect the outcomes of these infections. We additionally defined CRGN as an organism demonstrating resistance to at least one carbapenem antibiotic and therefore could not assess the risk factors paticularly for carbapenemase-producing CRGN, which may be distinct from those for non-carbapenemase-producing CRGN.
CRGN infections are still major cause of morbidity, mortality and healthcare associated infections. In this study, we evaluated the patients with BSI due to a CRGN microorganism and compared with other infection types. The risk factors and outcomes were similar except prior cephalosporin exposure.
Conclusions
We have to enhance the infection control programs and prevent the patients from redundant antibiotic exposure. The current knowledge's are based on adult studies due to lack of prospective and case-control design studies. Therefore, further larger and prospective design studies are needed. 
